학술논문
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders
Document Type
Article
Author
Turdi, H.; Chao, H.; Hangeland, J.J.; Ahmad, S.; Meng, W.; Brigance, R.; Zhao, G.; Wang, W.; Moore, F.; Ye, X.-Y.; Mathur, A.; Hou, X.; Kempson, J.; Wu, D.-R.; Li, Y.-X.; Robl, J.A.; Lawrence, R.M.; Devasthale, P.; Azzara, A.V.; Ma, Z.; Chu, C.-H.; Chen, L.; Cullen, M.J.; Rooney, S.; Harvey, S.; Kopcho, L.; Panemangelor, R.; Abell, L.; O'Malley, K.; Keim, W.J.; Pelleymounter, M.A.; Whaley, J.M.; Cheng, D.; Dierks, E.; Chang, S.; Foster, K.; Apedo, A.; Harden, D.; Dabros, M.; Gao, Q.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 14 October 2021, 64(19):14773-14792)
Subject
Language
English
ISSN
15204804
00222623
00222623